Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Return on Invested Capital (2016 - 2026)

Pharma-Bio Serv filings provide 14 years of Return on Invested Capital readings, the most recent being 0.0% for Q1 2026.

  • On a quarterly basis, Return on Invested Capital changed 0.0% to 0.0% in Q1 2026 year-over-year; TTM through Jan 2026 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Invested Capital hit 0.0% in Q1 2026 for Pharma-Bio Serv, down from 0.0% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q3 2023 to a low of 0.0% in Q2 2022.
  • Median Return on Invested Capital over the past 5 years was 0.0% (2025), compared with a mean of 0.0%.
  • The widest YoY moves for Return on Invested Capital: up 0bps in 2022, down 0bps in 2022.
  • Pharma-Bio Serv's Return on Invested Capital stood at 0.0% in 2022, then dropped by -12bps to 0.0% in 2023, then tumbled by -280bps to 0.0% in 2024, then surged by 35bps to 0.0% in 2025, then dropped by -18bps to 0.0% in 2026.
  • The last three reported values for Return on Invested Capital were 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025) per Business Quant data.